{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:08:43Z","timestamp":1761844123054},"reference-count":38,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.3892\/or.2011.1572","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T23:02:21Z","timestamp":1322780541000},"page":"1104-1110","source":"Crossref","is-referenced-by-count":11,"title":["A bone-seeking clone exhibits different biological properties from the ACHN parental human renal cell carcinoma in vivo and in vitro"],"prefix":"10.3892","volume":"27","author":[{"given":"JIANG","family":"WANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANMIN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CAIHONG","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HENG","family":"ZENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN","family":"QI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FENG-JIN","family":"GUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2011,11,30]]},"reference":[{"key":"key20180107213813_b1-or-27-04-1104","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0022-5347(01)61897-4","article-title":"Renal cell carcinoma: management of advanced disease","volume":"161","author":"Figlin","year":"1999","journal-title":"J Urol"},{"key":"key20180107213813_b2-or-27-04-1104","first-page":"379","article-title":"The skeletal metastatic complications of renal cell carcinoma","volume":"19","author":"Zekri","year":"2001","journal-title":"Int J Oncol"},{"key":"key20180107213813_b3-or-27-04-1104","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"key20180107213813_b4-or-27-04-1104","first-page":"269","article-title":"Bone metastases studied in experimental animals","volume":"1981","author":"Galasko","year":"1981","journal-title":"Clin Orthop Relat Res"},{"key":"key20180107213813_b5-or-27-04-1104","first-page":"283","article-title":"Surgical treatment of osseous metastases in patients with renal cell carcinoma","author":"Durr","year":"1999","journal-title":"Clin Orthop Relat Res"},{"key":"key20180107213813_b6-or-27-04-1104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2004.07.013","article-title":"Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids","volume":"226","author":"Iwai","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"key20180107213813_b7-or-27-04-1104","first-page":"4233","article-title":"Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis","volume":"54","author":"Takahashi","year":"1994","journal-title":"Cancer Res"},{"key":"key20180107213813_b8-or-27-04-1104","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0022-5347(05)67889-5","article-title":"Systemic therapy for renal cell carcinoma","volume":"163","author":"Motzer","year":"2000","journal-title":"J Urol"},{"key":"key20180107213813_b9-or-27-04-1104","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10555-007-9090-y","article-title":"Renal cell carcinoma bone metastasis - elucidating the molecular targets","volume":"26","author":"Weber","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107213813_b10-or-27-04-1104","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI112677","article-title":"Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures","volume":"78","author":"Takahashi","year":"1986","journal-title":"J Clin Invest"},{"key":"key20180107213813_b11-or-27-04-1104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1359\/jbmr.061005","article-title":"TGF-beta promotes the establishment of renal cell carcinoma bone metastasis","volume":"22","author":"Kominsky","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key20180107213813_b12-or-27-04-1104","first-page":"3407","article-title":"Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue","volume":"49","author":"Mydlo","year":"1989","journal-title":"Cancer Res"},{"key":"key20180107213813_b13-or-27-04-1104","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-8140(02)00131-7","article-title":"Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy","volume":"63","author":"Aebersold","year":"2002","journal-title":"Radiother Oncol"},{"key":"key20180107213813_b14-or-27-04-1104","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-4598-5-56","article-title":"Stromal derived factor-1 (SDF-1\/CXCL12) and CXCR4 in renal cell carcinoma metastasis","volume":"5","author":"Pan","year":"2006","journal-title":"Mol Cancer"},{"key":"key20180107213813_b15-or-27-04-1104","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cncr.11150","article-title":"Animal models of bone metastasis","volume":"97","author":"Rosol","year":"2003","journal-title":"Cancer"},{"key":"key20180107213813_b16-or-27-04-1104","first-page":"6876","article-title":"A murine model of experimental metastasis to bone and bone marrow","volume":"48","author":"Arguello","year":"1988","journal-title":"Cancer Res"},{"key":"key20180107213813_b17-or-27-04-1104","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI119435","article-title":"Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2","volume":"99","author":"Yoneda","year":"1997","journal-title":"J Clin Invest"},{"key":"key20180107213813_b18-or-27-04-1104","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3727\/096504009789745511","article-title":"A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319\/bone2 in natural killer cell-depleted severe combined immunodeficient mice","volume":"17","author":"Otsuka","year":"2009","journal-title":"Oncol Res"},{"key":"key20180107213813_b19-or-27-04-1104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2010.02.012","article-title":"A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells","volume":"295","author":"Liu","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180107213813_b20-or-27-04-1104","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ejca.2003.11.028","article-title":"Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development","volume":"40","author":"Kelland","year":"2004","journal-title":"Eur J Cancer"},{"key":"key20180107213813_b21-or-27-04-1104","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejca.2003.11.021","article-title":"Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages","volume":"40","author":"Bibby","year":"2004","journal-title":"Eur J Cancer"},{"key":"key20180107213813_b22-or-27-04-1104","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/3-540-26980-0_6","article-title":"Can animal models help us select specific compounds for cancer prevention trials?","volume":"166","author":"Hawk","year":"2005","journal-title":"Recent Results Cancer Res"},{"key":"key20180107213813_b23-or-27-04-1104","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ymthe.2004.08.013","article-title":"Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer","volume":"10","author":"Shaw","year":"2004","journal-title":"Mol Ther"},{"key":"key20180107213813_b24-or-27-04-1104","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose","volume":"261","author":"Hauschka","year":"1986","journal-title":"J Biol Chem"},{"key":"key20180107213813_b25-or-27-04-1104","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1073\/pnas.84.7.2024","article-title":"Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones","volume":"84","author":"Pfeilschifter","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107213813_b26-or-27-04-1104","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1101\/gad.13.7.804","article-title":"A mechanism of repression of TGFbeta\/Smad signaling by oncogenic Ras","volume":"13","author":"Kretzschmar","year":"1999","journal-title":"Genes Dev"},{"key":"key20180107213813_b27-or-27-04-1104","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1101\/gad.13.17.2196","article-title":"The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling","volume":"13","author":"Luo","year":"1999","journal-title":"Genes Dev"},{"key":"key20180107213813_b28-or-27-04-1104","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/46794","article-title":"Silencing of TGF-beta signalling by the pseudoreceptor BAMBI","volume":"401","author":"Onichtchouk","year":"1999","journal-title":"Nature"},{"key":"key20180107213813_b29-or-27-04-1104","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.286.5440.771","article-title":"Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein","volume":"286","author":"Stroschein","year":"1999","journal-title":"Science"},{"key":"key20180107213813_b30-or-27-04-1104","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20180107213813_b31-or-27-04-1104","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1200\/JCO.2005.01.186","article-title":"Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma","volume":"23","author":"Rini","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180107213813_b32-or-27-04-1104","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/MCB.19.2.1289","article-title":"Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells","volume":"19","author":"Gorospe","year":"1999","journal-title":"Mol Cell Biol"},{"key":"key20180107213813_b33-or-27-04-1104","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0006-2952(02)01168-1","article-title":"Signal transduction to hypoxia-inducible factor 1","volume":"64","author":"Semenza","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"key20180107213813_b34-or-27-04-1104","first-page":"309","article-title":"A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma","volume":"21","author":"Iguchi","year":"2002","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107213813_b35-or-27-04-1104","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.matbio.2008.06.005","article-title":"VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin","volume":"27","author":"Yang","year":"2008","journal-title":"Matrix Biol"},{"key":"key20180107213813_b36-or-27-04-1104","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S8756-3282(97)00292-5","article-title":"Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures","volume":"22","author":"Hurley","year":"1998","journal-title":"Bone"},{"key":"key20180107213813_b37-or-27-04-1104","first-page":"3317","article-title":"Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma","volume":"52","author":"Blay","year":"1992","journal-title":"Cancer Res"},{"key":"key20180107213813_b38-or-27-04-1104","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1200\/JCO.2004.06.121","article-title":"Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6 - from the Groupe Francais d\u2019Immunotherapie","volume":"22","author":"Negrier","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2011.1572\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T08:22:59Z","timestamp":1639815779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2011.1572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,30]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,11,30]]},"published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.3892\/or.2011.1572"],"URL":"https:\/\/doi.org\/10.3892\/or.2011.1572","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,30]]}}}